Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,160 | 122 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $609.30 | 32 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $302.58 | 14 | $0 (2024) |
| ABBVIE INC. | $212.32 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $194.80 | 7 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $169.15 | 11 | $0 (2024) |
| Exact Sciences Corporation | $166.71 | 11 | $0 (2024) |
| PFIZER INC. | $88.51 | 5 | $0 (2024) |
| Mylan Specialty L.P. | $77.85 | 4 | $0 (2024) |
| Lilly USA, LLC | $67.65 | 4 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $60.78 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,618 | 93 | AstraZeneca Pharmaceuticals LP ($275.13) |
| 2023 | $203.32 | 12 | Novo Nordisk Inc ($67.03) |
| 2022 | $149.04 | 9 | Novo Nordisk Inc ($112.12) |
| 2021 | $189.51 | 8 | Novo Nordisk Inc ($168.06) |
All Payment Transactions
122 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Diabetes | ||||||
| 12/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: PAIN | ||||||
| 11/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Cardio-renal | ||||||
| 11/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Obesity | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Cardio-renal | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Obesity | ||||||
| 10/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Obesity | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.91 | General |
| Category: Obesity | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: PAIN | ||||||
| 08/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 176 | 217 | $17,944 | $9,829 |
| 2022 | 4 | 242 | 377 | $30,944 | $19,377 |
| 2021 | 5 | 299 | 456 | $29,879 | $20,524 |
| 2020 | 6 | 392 | 553 | $38,126 | $18,908 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 97 | 132 | $12,135 | $6,761 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 48 | 54 | $3,603 | $1,887 | 52.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $1,839 | $996.64 | 54.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 11 | 11 | $367.62 | $184.15 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 149 | 266 | $24,804 | $15,401 | 62.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 71 | 89 | $5,682 | $3,680 | 64.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 11 | 11 | $367.62 | $253.29 | 68.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 11 | 11 | $90.64 | $42.78 | 47.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 157 | 273 | $21,013 | $14,775 | 70.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 79 | 117 | $5,924 | $4,313 | 72.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 19 | 19 | $1,687 | $754.46 | 44.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2021 | 21 | 24 | $1,066 | $566.40 | 53.2% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 23 | 23 | $189.52 | $114.87 | 60.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 161 | 282 | $22,272 | $11,722 | 52.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 66 | 79 | $7,015 | $2,556 | 36.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 35 | $2,669 | $1,724 | 64.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 74 | 92 | $4,085 | $1,501 | 36.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 31 | 35 | $1,735 | $1,195 | 68.9% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Facility | 2020 | 14 | 14 | $197.74 | $133.37 | 67.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 16 | 16 | $152.40 | $75.91 | 49.8% |
About Stephanie Choate, APRN
Stephanie Choate, APRN is a Registered Nurse healthcare provider based in Sallisaw, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720570609.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Choate, APRN has received a total of $2,160 in payments from pharmaceutical and medical device companies, with $1,618 received in 2024. These payments were reported across 122 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,160).
As a Medicare-enrolled provider, Choate has provided services to 1,109 Medicare beneficiaries, totaling 1,603 services with total Medicare billing of $68,638. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family, Nurse Practitioner
- Location Sallisaw, OK
- Active Since 06/05/2018
- Last Updated 08/13/2025
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1720570609
Products in Payments
- Wegovy (Drug) $282.29
- VRAYLAR (Drug) $179.57
- Kerendia (Drug) $169.15
- Cologuard Collection Kit (Device) $166.71
- AIRSUPRA (Drug) $147.64
- Ozempic (Drug) $146.91
- AREXVY (Drug) $137.64
- Saxenda (Drug) $126.49
- FARXIGA (Drug) $103.14
- NURTEC ODT (Drug) $88.51
- YUPELRI (Drug) $77.85
- JARDIANCE (Drug) $69.77
- CAPLYTA (Drug) $60.78
- TRELEGY ELLIPTA (Drug) $57.16
- MOUNJARO (Drug) $52.29
- REXULTI (Drug) $50.70
- Rybelsus (Drug) $35.51
- NEXPLANON (Drug) $33.76
- UBRELVY (Drug) $32.75
- INTELLIS ADAPTIVESTIM (Device) $23.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Sallisaw
Chelsea Real, Dnp, Aprn, Fnp-C, DNP, APRN, FNP-C
Registered Nurse — Payments: $780.09
Linda O'mahony
Registered Nurse
Mrs. Stephanie Erwin
Registered Nurse
Michele Hensley, Rn, RN
Registered Nurse
Tiffiney Swearingen, Rn, RN
Registered Nurse